4//SEC Filing
De La Rosa Abel 4
Accession 0001415889-22-000462
CIK 0001818844other
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 5:24 PM ET
Size
5.1 KB
Accession
0001415889-22-000462
Insider Transaction Report
Form 4
De La Rosa Abel
Director
Transactions
- Purchase
Common Stock
2022-01-07$5.90/sh+4,000$23,584→ 4,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $5.8375 to $6.00, inclusive. The reporting person undertakes to provide Virios Therapeutics, Inc. ("Virios"), any security holder of Virios or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
Documents
Issuer
Virios Therapeutics, Inc.
CIK 0001818844
Entity typeother
Related Parties
1- filerCIK 0001825983
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 5:24 PM ET
- Size
- 5.1 KB